Rupture of a giant coronary artery aneurysm due to Kawasaki disease

Thomas M T Hwong; Ahmed A Arifi; Innes Y P Wan; K H Thung; Song Wan; Rita Y T Sung; Anthony P C Yim

doi:10.1016/j.athoracsur.2003.06.015

Rupture of a giant coronary artery aneurysm due to Kawasaki disease

Ann Thorac Surg. 2004 Aug;78(2):693-5. doi: 10.1016/j.athoracsur.2003.06.015.

Authors

Thomas M T Hwong¹, Ahmed A Arifi, Innes Y P Wan, K H Thung, Song Wan, Rita Y T Sung, Anthony P C Yim

Affiliation

¹ Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

PMID: 15276552
DOI: 10.1016/j.athoracsur.2003.06.015

Abstract

Coronary artery aneurysm requiring surgery is rare. We report a case of a ruptured giant coronary artery aneurysm due to Kawasaki vasculitis which presented with cardiac arrest and was successfully treated by emergency coronary artery bypass grafting. The controversies surrounding the management of this disease are also discussed.

Publication types

Case Reports

MeSH terms

Anticoagulants / therapeutic use
Aspirin / therapeutic use
Cardiac Tamponade / etiology
Child, Preschool
Combined Modality Therapy
Coronary Aneurysm / diagnostic imaging
Coronary Aneurysm / etiology*
Coronary Aneurysm / surgery
Coronary Artery Bypass*
Disease Progression
Emergencies
Heart Arrest / etiology
Heart Diseases / etiology
Heparin / therapeutic use
Humans
Immunoglobulins, Intravenous / therapeutic use
Male
Mucocutaneous Lymph Node Syndrome / drug therapy
Mucocutaneous Lymph Node Syndrome / etiology*
Mucocutaneous Lymph Node Syndrome / therapy
Platelet Aggregation Inhibitors / therapeutic use
Remission Induction
Rupture, Spontaneous
Thrombectomy
Thrombosis / etiology
Ultrasonography

Substances

Anticoagulants
Immunoglobulins, Intravenous
Platelet Aggregation Inhibitors
Heparin
Aspirin